- Home
- BBIO vs LEVI Comparison
BBIO vs LEVI Comparison
Compare BBIO & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- LEVI
- Stock Information
- Founded
- BBIO 2015
- LEVI 1853
- Country
- BBIO United States
- LEVI United States
- Employees
- BBIO N/A
- LEVI N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- LEVI Apparel
- Sector
- BBIO Health Care
- LEVI Consumer Discretionary
- Exchange
- BBIO Nasdaq
- LEVI Nasdaq
- Market Cap
- BBIO 8.0B
- LEVI 7.0B
- IPO Year
- BBIO 2019
- LEVI 2019
- Fundamental
- Price
- BBIO $42.78
- LEVI $18.83
- Analyst Decision
- BBIO Strong Buy
- LEVI Strong Buy
- Analyst Count
- BBIO 14
- LEVI 11
- Target Price
- BBIO $58.85
- LEVI $20.55
- AVG Volume (30 Days)
- BBIO 3.3M
- LEVI 2.2M
- Earning Date
- BBIO 07-31-2025
- LEVI 07-10-2025
- Dividend Yield
- BBIO N/A
- LEVI 2.73%
- EPS Growth
- BBIO N/A
- LEVI 195.92
- EPS
- BBIO N/A
- LEVI 0.89
- Revenue
- BBIO $127,415,000.00
- LEVI $6,401,900,000.00
- Revenue This Year
- BBIO $102.05
- LEVI N/A
- Revenue Next Year
- BBIO $54.69
- LEVI $4.45
- P/E Ratio
- BBIO N/A
- LEVI $21.50
- Revenue Growth
- BBIO N/A
- LEVI 7.23
- 52 Week Low
- BBIO $21.72
- LEVI $12.17
- 52 Week High
- BBIO $45.48
- LEVI $21.95
- Technical
- Relative Strength Index (RSI)
- BBIO 62.54
- LEVI 63.92
- Support Level
- BBIO $39.65
- LEVI $17.96
- Resistance Level
- BBIO $45.48
- LEVI $18.65
- Average True Range (ATR)
- BBIO 1.56
- LEVI 0.45
- MACD
- BBIO 0.15
- LEVI 0.09
- Stochastic Oscillator
- BBIO 60.90
- LEVI 99.56
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.